( NASDAQ-NMS:NBRV )

News from F2G Ltd. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Oct 26, 2016, 06:19 ET F2G Ltd Announces Publication of Initial F901318 Data in Scientific Journal PNAS

- F901318 Represents a Novel Class of Antifungal Drug, the Orotomides - Currently in Clinical Development for the Treatment of Invasive...


Jul 11, 2016, 04:00 ET F2G Ltd Announces the Appointment of Ralf Schmid to the Position of Chief Financial Officer

F2G Ltd, the UK-based antifungal drug discovery and development company, today announced the appointment of Ralf Schmid to the position of Chief...


Jun 20, 2016, 05:03 ET F2G Ltd Announces $60 Million Financing to Progress Development of Novel Antifungal Agents

Funding to Take Lead Compound Through to Product Approval and Development of Pipeline Assets  F2G Ltd, the UK-based antifungal drug...